Dyne Therapeutics, Inc. (DYN)

CIK 1818794 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Dyne Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 202610-Q0001818794-26-000012
Nov 5, 20268-K0001818794-26-000013
Oct 22, 202640001814189-26-000007
Oct 6, 202640001193125-26-415584
Sep 29, 20268-K0001818794-26-000009
Sep 8, 20261440001972481-26-000280
Sep 8, 202640001498428-26-000005
Sep 8, 20261440001972481-26-000279
Sep 8, 202640001915598-26-000005
Sep 8, 202640001814189-26-000005
Sep 4, 20261440001972481-26-000278
Aug 17, 202640001697616-26-000002
Aug 17, 202640001498428-26-000004
Aug 17, 202640001915598-26-000004
Aug 17, 202640001814189-26-000004
Aug 17, 202640001577014-26-000016
Aug 14, 20261440001628280-26-057188
Aug 14, 20261440001628280-26-057190
Aug 14, 20261440001628280-26-057191
Aug 13, 20261440001972481-26-000260
Aug 13, 2026SCHEDULE 13G/A0001274173-26-000206
Aug 13, 20261440001972481-26-000258
Aug 13, 20261440001972481-26-000259
Aug 13, 20261440001628280-26-056843
Aug 13, 20261440001628280-26-056842